SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 492 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,171,523 | +200.3% | 759,706 | +172.4% | 0.02% | +200.0% |
| Q2 2023 | $53,666,893 | -54.8% | 278,847 | -52.4% | 0.01% | -53.8% |
| Q1 2023 | $118,722,132 | +87.2% | 586,369 | +18.8% | 0.01% | +85.7% |
| Q4 2022 | $63,435,105 | -8.4% | 493,620 | -2.5% | 0.01% | -12.5% |
| Q3 2022 | $69,281,000 | -24.0% | 506,322 | -1.7% | 0.01% | -20.0% |
| Q2 2022 | $91,168,000 | +17.3% | 515,248 | -4.5% | 0.01% | +25.0% |
| Q1 2022 | $77,718,000 | -31.8% | 539,519 | -26.8% | 0.01% | -27.3% |
| Q4 2021 | $113,974,000 | +20.4% | 737,217 | +32.2% | 0.01% | +10.0% |
| Q3 2021 | $94,700,000 | +6.4% | 557,719 | -1.1% | 0.01% | +11.1% |
| Q2 2021 | $88,993,000 | -2.2% | 563,673 | -14.0% | 0.01% | -10.0% |
| Q1 2021 | $90,984,000 | -7.2% | 655,214 | +17.0% | 0.01% | -23.1% |
| Q4 2020 | $98,083,000 | – | 560,021 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |